MarketInOut Stock Screener Log In | Sign Up

Bionano Genomics Inc

NASDAQ • Healthcare • Medical Instruments & Supplies • Quote as of 10/30/2026
Bionano Genomics Inc stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization14.6 mln
Float11.08 mln
Earnings Date11/10/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.92
Highly reliable

Relative Strength

18 / 100
Significantly lagging

Debt / Equity

0.21
Very low leverage

Pre-Tax Margin

-106%
Severely loss-making

ROE

-77.07
Deeply negative

Business Description

Bionano Genomics is a San Diego-based company founded in 2003 that operates globally across the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company develops tools, instruments, and software that help genetics laboratories study the human genome, identify structural variations in DNA, and uncover the causes of genetic conditions. It also runs its own testing services, helping to diagnose disorders such as autism, developmental delays, Fragile X syndrome, and certain muscular diseases.

Key Fundamentals

EPS-3.02
ROE-77.07
RPS3.16
ROIC-75.03
ROA-47.15
Interest Cover-151
EBITDA, mln-22.29
EV / EBITDA-0.47
EV / EBIT-0.33
Revenue, mln30.18
EV / Revenue0.34

Quote Details

Last 1.15
Change -0.05 (-4.17%)
Open 1.18
Volume 194,981
Turnover 224,228
Average Volume 206,925

Financial Ratios

Pre-Tax Profit Margin-106
Leverage Ratio1.51
Current Ratio2.48
Price / Book0.46
Price / Tangible Book0.48
Debt / Equity0.21
Price / Sales0.35

Financial Strength

Altman Z-Score-22.32
Piotroski F-Score 5 / 9
Beneish M-Score-3.92
Short Ratio0.58
Short % of Float11.55

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.77% 79 / 100   
1 Month -26.75% 13 / 100   
2 Months 6.48% 85 / 100   
6 Months -2.54% 46 / 100   
1 Year -36.81% 24 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog